1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East Africa Pulmonary Arterial Hypertension Market – By Drugs

1.3.2        Middle East Africa Pulmonary Arterial Hypertension Market – By Type

1.3.3        Middle East Africa Pulmonary Arterial Hypertension Market – By Route of Administration

1.3.4        Middle East Africa Pulmonary Arterial Hypertension Market – By Distribution Channel

1.3.5        Middle East Africa Pulmonary Arterial Hypertension Market – By Country

2.           Middle East Africa Pulmonary Arterial Hypertension Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East Africa Pulmonary Arterial Hypertension Market – Market Landscape

4.1         Overview

4.2         Middle East Africa PEST Analysis

4.3         Experts Opinion

5.           Middle East Africa Pulmonary Arterial Hypertension Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Incidence of Pulmonary Arterial Hypertension

5.2         Market Restraints

5.2.1        Side Effects of Drugs Used for Treatment of Pulmonary Arterial Hypertension

5.3         Market Opportunities

5.3.1        Availability of Generics at Affordable Costs Due to Growing Patent Expiration

5.4         Future Trend

5.4.1        Rising Clinical Trials for Drugs Development to Treat Pulmonary Arterial Hypertension

5.5         Impact analysis

6.           Pulmonary Arterial Hypertension Market – Middle East Africa Analysis

6.1         Middle East Africa Pulmonary Arterial Hypertension Market Revenue Forecast and Analysis

7.           Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Drugs

7.1         Overview

7.2         Middle East Africa Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)

7.3         Endothelin Receptor Antagonists (ERAs)

7.3.1        Overview

7.3.2        Endothelin Receptor Antagonists (ERAs): Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Prostacyclin and Prostacyclin Analogs

7.4.1        Overview

7.4.2        Prostacyclin and Prostacyclin Analogs: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

7.5         SGC Stimulators

7.5.1        Overview

7.5.2        sGC Stimulators: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Pde-5 Dipsticks

7.6.1        Overview

7.6.2        Pde-5 Dipsticks: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

8.           Middle East Africa Pulmonary Arterial Hypertension Market Analysis and Forecasts to 2028 – by Type

8.1         Overview

8.2         Middle East Africa Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)

8.3         Branded

8.3.1        Overview

8.3.2        Branded: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Generics

8.4.1        Overview

8.4.2        Generics: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9.           Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Route of Administration

9.1         Overview

9.2         Middle East Africa Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)

9.3         Oral

9.3.1        Overview

9.3.2        Oral: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Intravenous/ Subcutaneous

9.4.1        Overview

9.4.2        Intravenous/ Subcutaneous: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Inhalational

9.5.1        Overview

9.5.2        Inhalational: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10.        Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Distribution Channel

10.1      Overview

10.2      Middle East Africa Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)

10.3      Hospital Pharmacies and Clinics

10.3.1     Overview

10.3.2     Hospital Pharmacies and Clinics: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Online Pharmacies

10.4.1     Overview

10.4.2     Online Pharmacies: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Retail Pharmacies

10.5.1     Overview

10.5.2     Retail Pharmacies: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.        Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – Country Analysis

11.1      Overview

11.1.1     Middle East & Africa: Pulmonary Arterial Hypertension Market, by Country, 2021 & 2028 (%)

11.1.1.1       UAE: Pulmonary Arterial Hypertension Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       UAE: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3       UAE: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.1.4       UAE: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.1.5       UAE: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.1.6       UAE: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.1.2       Saudi Arabia: Pulmonary Arterial Hypertension Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Saudi Arabia: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3       Saudi Arabia: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.2.4       Saudi Arabia: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.2.5       Saudi Arabia: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.2.6       Saudi Arabia: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.1.3       South Africa: Pulmonary Arterial Hypertension Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       South Africa: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3       South Africa: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.3.4       South Africa: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.3.5       South Africa: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.3.6       South Africa: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.1.4       Rest of the Middle East Africa: Pulmonary Arterial Hypertension Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       Rest of the Middle East Africa: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.3       Rest of the Middle East Africa: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.1.4.4       Rest of the Middle East Africa: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.1.4.5       Rest of the Middle East Africa: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.1.4.6       Rest of the Middle East Africa: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

12.        Middle East Africa Pulmonary Arterial Hypertension Market – Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Johnson & Johnson

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Gilead Sciences Inc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Novartis AG

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      GSK Plc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Teva Pharmaceutical Industries Ltd

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Lupin Ltd

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Pfizer Inc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms 

LIST OF TABLES

Table 1.             Middle East Africa Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             UAE Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 3.             UAE Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             UAE Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 5.             UAE Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Saudi Arabia Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Saudi Arabia Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Saudi Arabia Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Saudi Arabia Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 10.          South Africa Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 11.          South Africa Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          South Africa Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 13.          South Africa Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Rest of the Middle East and Africa Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Rest of the Middle East and Africa Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of the Middle East Africa Pulmonary Arterial Hypertension Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of the Middle East Africa Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Organic Developments in the Middle East Africa pulmonary arterial hypertension market

Table 19.          Inorganic Developments in the Middle East Africa pulmonary arterial hypertension market

Table 20.          Glossary of Terms 

LIST OF FIGURES

Figure 1.           Middle East Africa Pulmonary Arterial Hypertension Market Segmentation

Figure 2.           Middle East Africa Pulmonary Arterial Hypertension Market – By Country

Figure 3.           Middle East Africa Pulmonary Arterial Hypertension Market Overview

Figure 4.           Prostacyclin and Prostacyclin Analogs Segment Held Largest Share by Drugs of the Middle East Africa Pulmonary Arterial Hypertension Market

Figure 5.           Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6.           Middle East Africa: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Middle East Africa Pulmonary Arterial Hypertension Market Impact Analysis of Drivers and Restraint

Figure 9.           Middle East Africa Pulmonary Arterial Hypertension Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 10.        Middle East Africa Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)

Figure 11.        Endothelin Receptor Antagonists (ERAs): Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Prostacyclin and Prostacyclin Analogs: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        sGC Stimulators: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Pde-5 Dipsticks: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Middle East Africa Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)

Figure 16.        Branded: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Generics: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Middle East Africa Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)

Figure 19.        Oral: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Intravenous/ Subcutaneous: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Inhalational: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Middle East Africa Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)

Figure 23.        Hospital Pharmacies and Clinics: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Online Pharmacies: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Retail Pharmacies: Middle East Africa Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Middle East & Africa: Pulmonary Arterial Hypertension Market, by Key Country – Revenue (2021) (US$ Million)

Figure 27.        UAE: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Saudi Arabia: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        South Africa: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.          Rest of the Middle East and Africa: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)